Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

July 17, 2014

VICC’s Abramson lands breast cancer clinical research award

Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF).

By VUMC News and Communications
July 10, 2014

Pietenpol named to IOM Cancer Policy Forum

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies.

By VUMC News and Communications
July 2, 2014

Tennessee-based congressional staff spend day at Vanderbilt

Tennessee-based congressional staff members spent the day on campus June 25 to learn firsthand about Vanderbilt services and resources.

By VUMC News and Communications
June 19, 2014

Vanderbilt recognized again for cancer prevention activities

By VUMC News and Communications
June 19, 2014

VICC researchers in spotlight at national cancer conference

New Vanderbilt research suggests patients with advanced melanoma — the most deadly form of skin cancer — could safely benefit from a combination of immunotherapy and targeted therapies aimed at specific gene mutations.

By VUMC News and Communications
May 29, 2014

My Cancer Genome launches new mobile app

My Cancer Genome, an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled an updated free mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations.

By VUMC News and Communications
May 29, 2014

Exploring Wilms tumor race disparity

Unique molecular "fingerprints" could explain the disparity in Wilms tumor incidence and point to novel, race-specific therapeutic targets.
By Leigh MacMillan
May 22, 2014

Personalized care, gene testing highlighted at VICC retreat

Using enhanced gene mutation testing to provide precision therapy for cancer patients was one of the themes at the annual Vanderbilt-Ingram Cancer Center (VICC) scientific retreat, held May 15 at the Vanderbilt Student Life Center.
By VUMC News and Communications
May 22, 2014

Cellular forces aid tumor invasion

The contractile machinery inside tumor cells increases invasive properties, suggesting it might be a good target to inhibit cancer cell spread.
By VUMC News and Communications
May 21, 2014

VICC Cancer Survivorship Celebration set for June 8

Music will set the tone for Vanderbilt-Ingram Cancer Center’s annual Cancer Survivorship Celebration for patients, friends and families.
By VUMC News and Communications
May 8, 2014

PET probe detects dying tumor cells

A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine.
By Leigh MacMillan
May 1, 2014

Photo: Head and neck cancer screening

By VUMC News and Communications
April 30, 2014

Potential mechanism for myeloma drug’s variable toxicity

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
By Leigh MacMillan
1 … 44 45 46 47 48 … 58